These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10461544)

  • 21. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination.
    Oyama F; Cairns NJ; Shimada H; Oyama R; Titani K; Ihara Y
    J Neurochem; 1994 Mar; 62(3):1062-6. PubMed ID: 8113792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
    Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cPLA2 and desaturases underlie the tau hyperphosphorylation offset induced by BACE knock-down in neuronal primary cultures.
    Villamil-Ortiz JG; Cardona-Gómez GP
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3696-3707. PubMed ID: 30251689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel correlation between the levels of beta-amyloid protein precursor and tau transcripts in the aged human brain.
    Oyama F; Shimada H; Oyama R; Titani K; Ihara Y
    J Neurochem; 1992 Sep; 59(3):1117-25. PubMed ID: 1494902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A.
    Arendt T; Holzer M; Fruth R; Brückner MK; Gärtner U
    Neurobiol Aging; 1998; 19(1):3-13. PubMed ID: 9562497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
    Stoppelkamp S; Bell HS; Palacios-Filardo J; Shewan DA; Riedel G; Platt B
    Exp Neurol; 2011 Jun; 229(2):226-37. PubMed ID: 21295028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau.
    Sotiropoulos I; Catania C; Riedemann T; Fry JP; Breen KC; Michaelidis TM; Almeida OF
    J Neurochem; 2008 Oct; 107(2):385-97. PubMed ID: 18691381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons.
    Lacovich V; Espindola SL; Alloatti M; Pozo Devoto V; Cromberg LE; Čarná ME; Forte G; Gallo JM; Bruno L; Stokin GB; Avale ME; Falzone TL
    J Neurosci; 2017 Jan; 37(1):58-69. PubMed ID: 28053030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
    Sun J; Zhang X; Wang C; Teng Z; Li Y
    Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures.
    Davis DR; Brion JP; Couck AM; Gallo JM; Hanger DP; Ladhani K; Lewis C; Miller CC; Rupniak T; Smith C
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):941-9. PubMed ID: 7639714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.
    Héraud C; Goufak D; Ando K; Leroy K; Suain V; Yilmaz Z; De Decker R; Authelet M; Laporte V; Octave JN; Brion JP
    Neurobiol Dis; 2014 Feb; 62():100-12. PubMed ID: 24076100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.